Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19.


Share:

Comments

Comentarios de Facebook